High Content Screening for Inhibitors of Protein Interactions and Post-translational Modifications in Primary Cells by Proximity Ligation

The cost of developing new drugs is a major obstacle for pharmaceutical companies and academia with many drugs identified in the drug discovery process failing approval for clinical use due to lack of intended effect or because of severe side effects. Since the early 1990s, high throughput screening...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Leuchowius, Karl-Johan, Jarvius, Malin, Wickström, Malin, Rickardson, Linda, Landegren, Ulf, Larsson, Rolf, Söderberg, Ola, Fryknäs, Mårten, Jarvius, Jonas
التنسيق: Artigo
اللغة:Inglês
منشور في: The American Society for Biochemistry and Molecular Biology 2010
الموضوعات:
Research
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2808263/
https://ncbi.nlm.nih.gov/pubmed/19864249
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1074/mcp.M900331-MCP200
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة